?β-Estradiol 17-Acetate Crude | High-Purity Estrogen Intermediate for Pharma & Research?

?Product Overview?

β-Estradiol 17-Acetate Crude is a key estrogen derivative widely used as an intermediate in ?hormone therapy? and ?pharmaceutical API synthesis?. It plays a vital role in estrogen-related research and drug development, particularly in ?breast cancer treatment? and ?endocrine disorder therapies?.

?Key Applications?:

• ?Pharmaceutical intermediates?

   for steroid hormone synthesis

• ?Research reagents?

   in oncology and endocrinology studies

• ?Anti-aging formulations?

   and hormone replacement therapies

?Key Benefits?

? ?High Purity?

• ≥99% purity validated via ?HPLC/GC-MS?with ≤0.5% impurities.

? ?Multi-Industry Utility?

• Essential for synthesizing ?estrogen-based APIs? and ?steroid derivatives?.

? ?Stable Storage?

•  Long-term stability under ?-20°C storage? with a 2-year shelf life.

?Applications?

     ?? ?Pharmaceutical Development?

• Core precursor for ?breast cancer drugs? targeting estrogen suppression.

       ?? ?Research & Diagnostics?

• Used in studies on hormone receptors and endocrine system modulation.

• ?? ?Hormone Therapy?

• Critical in formulations for menopause management and osteoporosis prevention.

?Quality Assurance?

• Manufactured under ?cGMP standards? with batch-specific COA.

• Complies with ?USP/EP specifications? for pharmaceutical-grade intermediates.

?Market Trends?

The global ?breast cancer therapeutics market? is projected to grow at a CAGR of 8.2% (2025-2030), driven by rising demand for hormone-targeted therapies. β-Estradiol derivatives remain pivotal in advancing precision oncology and personalized medicine.